Overview
Reactive arthritis, often affecting the knee, is an inflammatory arthropathy that typically develops following an infection in another part of the body, commonly the gastrointestinal or genitourinary tract. It is characterized by acute onset of joint inflammation, usually asymmetric and monoarticular initially, though it can become oligoarticular or polyarticular over time. This condition predominantly affects young adults, particularly those with recent infections or genetic predispositions like HLA-B27 positivity. Accurate diagnosis and timely intervention are crucial to prevent chronic joint damage and disability. Understanding reactive arthritis in the context of left knee involvement is vital for clinicians to manage symptoms effectively and prevent long-term sequelae, impacting patient quality of life significantly. 13Pathophysiology
Reactive arthritis arises from an autoimmune response triggered by an infectious agent, often bacteria such as Salmonella, Shigella, Campylobacter, or Chlamydia. The molecular and cellular mechanisms involve molecular mimicry, where bacterial antigens resemble host tissue antigens, leading to cross-reactivity of the immune system. This cross-reactivity results in the production of autoantibodies and pro-inflammatory cytokines, such as TNF-α and IL-17, which target synovial tissues in the knee. The initial inflammatory response can lead to synovitis, characterized by infiltration of neutrophils and later macrophages and lymphocytes, causing pain, swelling, and stiffness. Over time, chronic inflammation may result in cartilage and bone erosion if left untreated. The involvement of specific HLA types, particularly HLA-B27, further predisposes individuals to more severe and persistent joint manifestations. 34Epidemiology
The incidence of reactive arthritis varies but is estimated to be around 15-20 cases per 100,000 person-years, with a slight male predominance. It typically affects individuals aged 15 to 40 years, though it can occur at any age. Geographic distribution often correlates with regions where specific triggering infections are more prevalent. Risk factors include recent gastrointestinal or genitourinary infections, genetic predispositions (especially HLA-B27), and certain occupational exposures. Trends suggest an increasing awareness and reporting due to improved diagnostic criteria and surveillance systems, though true incidence changes are less clear. 35Clinical Presentation
Patients with reactive arthritis affecting the left knee often present with an acute onset of unilateral knee pain, swelling, and stiffness, typically within weeks of an infectious trigger. Symptoms may include warmth, erythema, and limited range of motion. Early in the course, the presentation can be monoarticular, but it may progress to involve other joints in a sequential or simultaneous manner. Red-flag features include severe joint effusion, rapid joint destruction, and systemic symptoms like fever, rash, or uveitis, which suggest a more complex inflammatory process or overlap with other autoimmune conditions. Prompt recognition of these features is crucial for timely intervention and to differentiate from other arthritides. 34Diagnosis
The diagnosis of reactive arthritis in the context of left knee involvement involves a combination of clinical evaluation and specific diagnostic criteria. Key steps include:Specific Criteria:
Management
First-Line Treatment
Specifics:
Second-Line Treatment
Specifics:
Refractory Cases / Specialist Escalation
Specifics:
Complications
Management Triggers:
Prognosis & Follow-up
The prognosis for reactive arthritis varies; many patients experience spontaneous remission within months, while others may develop chronic arthritis. Prognostic indicators include early diagnosis, prompt treatment, and absence of HLA-B27. Regular follow-up every 3-6 months is recommended initially, focusing on clinical assessment, inflammatory markers, and imaging to monitor disease activity and joint health. Long-term follow-up intervals can be extended to annually once remission is achieved. 34Special Populations
Key Recommendations
References
1 Wilson JM, Broida SE, Maradit-Kremers H, Browne JB, Springer BD, Berry DJ et al.. Is the American Joint Replacement Registry Able to Correctly Classify Revision Total Knee Arthroplasty Procedural Diagnoses?. The Journal of arthroplasty 2023. link 2 Maniar RN, Maniar PR, Chanda D, Gajbhare D, Chouhan T. What is the Responsiveness and Respondent Burden of the New Knee Society Score?. Clinical orthopaedics and related research 2017. link 3 McGinnis K, Snyder-Mackler L, Flowers P, Zeni J. Dynamic joint stiffness and co-contraction in subjects after total knee arthroplasty. Clinical biomechanics (Bristol, Avon) 2013. link 4 Read PJ, Pedley JS, Eirug I, Sideris V, Oliver JL. Impaired Stretch-Shortening Cycle Function Persists Despite Improvements in Reactive Strength After Anterior Cruciate Ligament Reconstruction. Journal of strength and conditioning research 2022. link 5 Saltzman BM, Meyer MA, Weber AE, Poland SG, Yanke AB, Cole BJ. Prospective Clinical and Radiographic Outcomes After Concomitant Anterior Cruciate Ligament Reconstruction and Meniscal Allograft Transplantation at a Mean 5-Year Follow-up. The American journal of sports medicine 2017. link 6 Ranawat CS. Design may be counterproductive for optimizing flexion after TKR. Clinical orthopaedics and related research 2003. link